Product Details
Denoza
Denosumab60 mg/mL
Solution for Subcutaneous Injection
1-mL Single-Use Prefilled Syringe (Preservative-Free)
DIN/PIN/NPN
02566265
Manufacturer
Apotex Inc.
Formulary Listing Date
2026-08-31
Unit Price
181.0710
Amount MOH Pays
181.0710
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
M05BX04
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 687 | Indefinite | To increase the bone mass in postmenopausal females with osteoporosis who are at high risk* for fracture who have failed, had intolerance to, or are unable to take a bisphosphonate therapy. *High risk of fracture based on a clinician's evaluation of the individual's risk of fractures that may include prior fragility fracture history and the Fracture Risk Assessment (FRAX) scores or another validated tool. |
| 688 | Indefinite | To increase the bone mass in males with osteoporosis who are at high risk* of fractures who have failed, had intolerance to, or are unable to take a bisphosphonate therapy. *High risk of fracture based on a clinician's evaluation of the individual's risk of fractures that may include prior fragility fracture history and the Fracture Risk Assessment (FRAX) scores or another validated tool. |
Requirements